Wise Investments

[Scrooge McDuck]

Interesting PR from PVCT.............

KNOXVILLE, Tenn., Jan 07, 2004 /PRNewswire-FirstCall via Comtex/ --

Provectus Pharmaceuticals (OTC Bulletin Board: PVCT) announced today that the Company is aggressively working to correct inaccurate reporting of proposed sales of shares by the Company directors.

In October 2003, Dr. Craig Dees and Dr. Tim Scott, two of our directors, each proposed to sell 94,876 shares of the Company's common stock. The Forms 144 which were actually filed with the Securities and Exchange Commission (the 'SEC') erroneously indicated that Drs. Dees and Scott proposed to sell significantly more shares. Drs. Dees and Scott instructed their broker to promptly amend the Forms 144 to show the correct amount of shares that were proposed to be sold. Even after these amendments were filed with the SEC, various reporting services have continued to erroneously report that Drs. Dees and Scott have proposed to sell significantly more shares. Since the original Forms 144 were filed, neither Dr. Dees nor Dr. Scott have sold any shares.

'It appears Form 144 reports have been filed which incorrectly lists numbers of Directors shares as free trading,'said Provectus CEO Dr. Craig Dees. 'We are continuing to work directly with the brokers and reporting services to correct the mistakes.'

Provectus Pharmaceuticals, Inc. develops pharmaceutical products in three sectors of the health-care industry: 1) prescription medications, 2) medical devices, and 3) OTC pharmaceuticals and cosmetics. Prescription drug products and devices treat diseases of the skin and many types of cancer. OTC products address complementary markets, primarily those involving skin care and comfort.

The company's corporate offices and laboratory are located at 7327 Oak Ridge Highway, Suite A, Knoxville, Tenn. 37931; 865/769-4012. For more information, contact the company at [e-mail] or visit the corporate Web site: www.pvct.com .